Diagnostic tests employed to identify cancer patients eligible for
treatment with targeted therapies, also known af companion diagnostics.
| # | Title | Description |
|---|---|---|
| 1 | Connection 9 | Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ... |
| 2 | Connection 9 | Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ... |
| 3 | Development of pharmacoDiagnostic Tests for Molecular Targeted ... | Page 1. Development of pharmacoDiagnostic TM Tests for Molecular Targeted Therapies Yoichi Tani, Yutaka Hatanaka and Kaoru Hashizume Dako Co. Ltd., Kyoto, Japan ... |
| 4 | Connection 9 | Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ... |
| 5 | Article Pharmacodiagnostic in Breast Cancer | Page 1. Connection 2008 | 39 T he molecular pathology of cancer is increasingly complex. Novel therapies and greater understanding ... |
| 6 | Pharmacodiagnostic and Personalized Medicine | Page 1. Connection 2008 | 31 Pharmacodiagnostic and Personalized Medicine Jan Trøst Jørgensen PhD Lars Rudbeck PhD Jan Trøst Jørgensen, PhD ... |
| 7 | “ ” | Page 1. | Connection 2008 24 “ Pharmacodiagnostics (companion diagnostics) have played prominent roles in the development and use of ... |
| 8 | Topoisomerase II Alpha and Chemotherapy Selection for Breast ... | Page 1. S everal different combination chemotherapy regimens have been shown to prolong disease-free or overall survival in patients ... |
| 9 | HER2 Indcations | - |
| 10 | Knowledge Center - pharmacoDiagnostics® | - |
| 11 | Pathology Products | - |
| 12 | Dako Scientific Magazine - Connection 9 | - |
| 13 | Dako Scientific Magazine - Connection 12 | - |
| 14 | Pathology Products | - |
| 15 | Pathology Products | - |
| 16 | Pathology Products | - |